Laurus Labs is forecast to grow earnings and revenue by 55.6% and 15.6% per annum respectively. EPS is expected to grow by 56.2% per annum. Return on equity is forecast to be 13.3% in 3 years.
Key information
55.6%
Earnings growth rate
56.2%
EPS growth rate
Pharmaceuticals earnings growth
18.3%
Revenue growth rate
15.6%
Future return on equity
13.3%
Analyst coverage
Good
Last updated
07 Nov 2024
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
BSE:540222 - Analysts future estimates and past financials data (INR Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
3/31/2027
74,517
7,982
3,301
11,211
13
3/31/2026
64,614
5,975
1,323
10,019
13
3/31/2025
55,442
3,444
225
10,205
13
9/30/2024
50,532
1,311
-3,277
2,489
N/A
6/30/2024
50,540
1,482
N/A
N/A
N/A
3/31/2024
50,408
1,606
-126
6,657
N/A
12/31/2023
49,821
1,879
N/A
N/A
N/A
9/30/2023
53,320
3,678
2,870
12,248
N/A
6/30/2023
56,834
5,637
N/A
N/A
N/A
3/31/2023
60,406
7,901
37
9,939
N/A
12/31/2022
60,845
9,176
N/A
N/A
N/A
9/30/2022
55,684
8,683
13
8,393
N/A
6/30/2022
51,960
8,374
N/A
N/A
N/A
3/31/2022
49,356
8,275
343
9,111
N/A
12/31/2021
49,227
8,937
N/A
N/A
N/A
9/30/2021
51,823
10,128
-1,705
7,112
N/A
6/30/2021
51,177
10,532
N/A
N/A
N/A
3/31/2021
48,135
9,836
442
7,330
N/A
12/31/2020
42,407
7,971
N/A
N/A
N/A
9/30/2020
36,819
5,977
1,548
5,427
N/A
6/30/2020
32,555
4,120
N/A
N/A
N/A
3/31/2020
28,317
2,553
1,252
3,474
N/A
12/31/2019
26,277
1,883
N/A
N/A
N/A
9/30/2019
24,276
1,326
1,613
3,538
N/A
6/30/2019
23,035
923
N/A
N/A
N/A
3/31/2019
22,919
938
434
2,977
N/A
12/31/2018
22,170
957
N/A
N/A
N/A
9/30/2018
21,665
1,127
N/A
N/A
N/A
6/30/2018
21,168
1,453
N/A
N/A
N/A
3/31/2018
20,562
1,676
N/A
3,425
N/A
12/31/2017
19,687
1,917
N/A
N/A
N/A
9/30/2017
19,954
2,019
N/A
N/A
N/A
6/30/2017
19,733
2,014
N/A
N/A
N/A
3/31/2017
19,046
1,881
N/A
3,320
N/A
3/31/2016
17,776
1,337
N/A
1,820
N/A
3/31/2015
13,266
684
N/A
-647
N/A
3/31/2014
11,597
972
N/A
1,212
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 540222's forecast earnings growth (55.6% per year) is above the savings rate (6.7%).
Earnings vs Market: 540222's earnings (55.6% per year) are forecast to grow faster than the Indian market (17.9% per year).
High Growth Earnings: 540222's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 540222's revenue (15.6% per year) is forecast to grow faster than the Indian market (10.5% per year).
High Growth Revenue: 540222's revenue (15.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 540222's Return on Equity is forecast to be low in 3 years time (13.3%).